Obesity and Metabolic Surgery in Patients With Type I Diabetes

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02612493

Enrollment

Registered

2015-11-23

Start date

2006-01-31

Completion date

2015-11-30

Last updated

2015-11-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type I Diabetes

Keywords

obesity surgery, type I diabetes, weight loss, insulin dosage, postsurgery metabolic changes

Brief summary

Obesity is the indication for bariatric surgery in type I diabetes. Interestingly postsurgery the patients improve remarkable in their need for insulin, not only in the daily total insulin dosage but also in the dosage of IU per kg.

Detailed description

The investigators performed a retrospective analysis on 16 patients undergoing weight loss surgery in obesity with concomitant type I diabetes. All patients were evaluated during Follow - Up to analyze insulin dosage and metabolic changes.

Interventions

OTHERObese patients with type I diabetes

Postsurgical follow - up in obese patients with type I diabetes

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* type I diabetes * BMI \> 40kg/m2

Exclusion criteria

* type II diabetes

Design outcomes

Primary

Measure	Time frame	Description
Insulin dosage	up to 8 years	Insulin dosage postsurgery

Secondary

Measure	Time frame
Excess Weight loss in %	up to 8 years
Change in HgA1c	up to 8 years
Change in lipids	up to 8 years

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026